India is looking more like the U.S. lately, and not in a good way. Photo: Dibyangshu Sarkar/AFP via Getty Images These days, headlines heralding some hopeful — or horrifying — new finding about the coronavirus are multiplying nearly as fast as the bug itself.
Even in that best-case scenario, it is not certain that the vaccine will confer long-term immunity, nor that the U.S. government will be prepared to rapidly manufacture and distribute the vaccine at the scale necessary for producing herd immunity. And there’s some reason to fear a critical mass of Americans will refuse to inoculate themselves against the virus .
At this point, though, no such medicines exist. The antiviral remdesivir has reduced recovery time among COVID-19 patients in clinical trials, and the steroid dexamethasone has prolonged survival among the severely ill in one British study. But neither of these remedies appear to be game-changing. To be sure, even if one stipulates the most optimistic reading of the present data, America remains mired in a devastating crisis. Absent a pharmaceutical breakthrough, there is a very good chance that coronavirus cases will plateau at a high level through the autumn and then rise substantially at the onset of winter, when cold weather forces Americans to retreat en masse to indoor spaces where the coronavirus spreads more readily.
Coronavirus has wrought mass death and economic devastation in wealthy countries with strong public-health systems and significant fiscal capacity. The implications of a prolonged outbreak in a developing nation like India — which lacks the means necessary for replacing the incomes of workers sidelined by shutdowns, and has fewer hospital beds per capita than any developed country — are harrowing. As is, India has already recorded more than 33,000 COVID-19 deaths.
These findings suggest that the novel coronavirus is not only capable of spreading through people who appear healthy, but that it is as capable of spreading through such individuals as it is through sniffling, shuddering wretches. If true, this would mean that the challenge of containing this virus once it gains a foothold is even more daunting than previously thought.
This long delay in the provision of results all but nullifies the primary public-health purpose of mass testing, which is to alert non-symptomatic carriers of coronavirus to their infection, thereby allowing them to self-isolate. Making matters worse, pipette shortages have led many labs to prioritize “testing for the sickest patients.
Balanced non politicized Covid coverage is a rarity these days, thank you
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: voguemagazine - 🏆 715. / 51 Read more »
Source: trtworld - 🏆 101. / 63 Read more »
Source: Allure_magazine - 🏆 473. / 51 Read more »
Source: CNBC - 🏆 12. / 72 Read more »
Source: MSNBC - 🏆 469. / 51 Read more »
Source: CNN - 🏆 4. / 95 Read more »